Skip to main content
. 2019 Jan 7;42(1):8–16. doi: 10.14348/molcells.2018.0436

Table 2.

Status of mutations in cancer cell lines harboring activating mutations of CTNNB1

Cancer type Cell Line Mutations

CTNNB1 APC TP53 BRAF KRAS
Colorectal cancer SW48 S33Y R2714C
CCK81 T41A Y159C P278H S273N
SNU407 T41A R726C G12D
HCT116 S45del G13D
LS180 S45F R1788C D211G G12D
Gastric cancer KE39 D32N V272L
AGS G34E G12D
SNU719 G34V
OCUM1 S45C
Endometrial cancer HEC265 D32V, X561_splice P1233L
HEC6 D32V V160A
HEC108 S37P, D207G S678G, A2388V, T2514I P151H
JHUEM2 S37C
SNGM S37P A2V G12V
Lung cancer MORCPR S33L P865L, A2122dup P152Rfs*18 G13C
SW1573 S33F G12C
LXF289 T41A R248W
HCC15 S45F, Y670* D2796G D259V
Liver cancer HUH6 G34V N239D, A159D
SNU398 S37C
Melanoma SKMEL1 S33C V600E
COLO783 S45del P27L V600E
*

Mutation data obtained from Cancer Cell Line Encyclopedia (Novartis/Broad, Nature, 2012) on cBioportal (www.cbioportal.org).

#

Abbreviation: del, deletion; dup, duplication; fs, frame shift; splice, splice site mutation;

*

stop codon